The Neurotransmitters Glycine and GABA Stimulate Glucagon-like Peptide-1 Release from the GLUTag Cell Line
Overview
Affiliations
The incretin hormone, glucagon-like peptide-1 (GLP-1) is released from intestinal L-cells following food ingestion. Its secretion is triggered by a range of nutrients, including fats, carbohydrates and proteins. We reported previously that Na(+)-dependent glutamine uptake triggered electrical activity and GLP-1 release from the L-cell model line GLUTag. However, whereas alanine also triggered membrane depolarization and GLP-1 secretion, the response was Na+ independent. A range of alanine analogues, including d-alanine, beta-alanine, glycine and l-serine, but not d-serine, triggered similar depolarizing currents and elevation of intracellular [Ca2+], a sensitivity profile suggesting the involvement of glycine receptors. In support of this idea, glycine-induced currents and GLP-1 release were blocked by strychnine, and currents showed a 58.5 mV shift in reversal potential per 10-fold change in [Cl-], consistent with the activation of a Cl(-)-selective current. GABA, an agonist of related Cl- channels, also triggered Cl- currents and secretion, which were sensitive to picrotoxin. GABA-triggered [Ca2+]i increments were abolished by bicuculline and partially impaired by (1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid (TPMPA), suggesting the involvement of both GABA(A) and GABA(C) receptors. Expression of GABA(A), GABA(C) and glycine receptor subunits was confirmed by RT-PCR. Glycine-triggered GLP-1 secretion was impaired by bumetanide but not bendrofluazide, suggesting that a high intracellular [Cl-] maintained by Na(+)-K(+)-2Cl- cotransporters is necessary for the depolarizing response to glycine receptor ligands. Our results suggest that GABA and glycine stimulate electrical activity and GLP-1 release from GLUTag cells by ligand-gated ion channel activation, a mechanism that might be important in responses to endogenous ligands from the enteric nervous system or dietary sources.
Yong G, Porsche C, Sitarik A, Fujimura K, McCauley K, Nguyen D Gut Microbes. 2023; 16(1):2290661.
PMID: 38117587 PMC: 10761186. DOI: 10.1080/19490976.2023.2290661.
Advances in the Management of Diabetes and Overweight using Incretin-based Pharmacotherapies.
Prajapati S Curr Diabetes Rev. 2023; 20(7):e131123223544.
PMID: 37962047 DOI: 10.2174/0115733998256797231009062744.
Glycine: The Smallest Anti-Inflammatory Micronutrient.
Aguayo-Ceron K, Sanchez-Munoz F, Gutierrez-Rojas R, Acevedo-Villavicencio L, Flores-Zarate A, Huang F Int J Mol Sci. 2023; 24(14).
PMID: 37510995 PMC: 10379184. DOI: 10.3390/ijms241411236.
Gutierrez-Rojas R, Aguayo-Ceron K, Vargas-De-Leon C, Cabrera-Becerra S, Almanza-Perez J, Huang F Life (Basel). 2022; 12(11).
PMID: 36362842 PMC: 9696036. DOI: 10.3390/life12111687.
A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders.
Delpire E, Ben-Ari Y Cells. 2022; 11(15).
PMID: 35954263 PMC: 9367773. DOI: 10.3390/cells11152419.